Nuformix (LON:NFX) Stock Price Down 11.1% – Time to Sell?

Nuformix plc (LON:NFX)’s share price traded down 11.1% during trading on Thursday . The company traded as low as GBX 0.24 and last traded at GBX 0.24. 8,196,036 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 36,088,453 shares. The stock had previously closed at GBX 0.27.

Nuformix Stock Down 8.0%

The stock has a fifty day moving average of GBX 0.26 and a 200-day moving average of GBX 0.23. The firm has a market capitalization of £4.85 million, a P/E ratio of -5.85 and a beta of 1.22.

Nuformix (LON:NFX) last posted its quarterly earnings data on Tuesday, January 27th. The company reported GBX (0.04) earnings per share for the quarter.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.